zokinvy
eigerbio europe limited - lonafarnib - progeria; laminopathies - iné alimentárny trakt a metabolizmus výrobky, - zokinvy is indicated for the treatment of patients 12 months of age and older with a genetically confirmed diagnosis of hutchinson-gilford progeria syndrome or a processing-deficient progeroid laminopathy associated with either a heterozygous lmna mutation with progerin-like protein accumulation or a homozygous or compound heterozygous zmpste24 mutation.
prednison 5 léčiva
zentiva, k.s., Česká republika - prednizón - 56 - hormona (lieČiva s hormonÁlnou aktivitou)
prednison 20 léčiva
zentiva, k.s., Česká republika - prednizón - 56 - hormona (lieČiva s hormonÁlnou aktivitou)
sorafenib accord
accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - antineoplastické činidlá - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.
sorafenib teva 200 mg
teva pharmaceuticals slovakia s.r.o., slovensko - sorafenib - 44 - cytostatica
sorafenib stada
stada arzneimittel ag, nemecko - sorafenib - 44 - cytostatica
sorafenib zentiva
zentiva, k.s., Česká republika - sorafenib - 44 - cytostatica
sorafenib sandoz 200 mg
sandoz pharmaceuticals d.d., slovinsko - sorafenib - 44 - cytostatica
sorafenib mylan 200 mg filmom obalené tablety
mylan ireland limited, Írsko - sorafenib - 44 - cytostatica
sorafenib sandoz 400 mg
sandoz pharmaceuticals d.d., slovinsko - sorafenib - 44 - cytostatica